Navigation Links
WuXi PharmaTech Announces Shareholder Resolutions Adopted at 2009 Annual General Meeting

SHANGHAI, Aug. 9 /PRNewswire-Asia/ -- WuXi PharmaTech (Cayman) Inc. (NYSE: WX) today announced shareholder resolutions adopted at its annual general meeting of shareholders held in Hong Kong on August 7, 2009.

(Logo: )

At the meeting, WuXi PharmaTech shareholders approved the re-election of incumbent Class B directors Xuesong Leng, Zhaohui Zhang, and Ning Zhao, each to serve a three-year term.

In addition, the WuXi shareholders approved an amendment to the Company's Memorandum of Articles and Association that revises Article 82 so that it no longer requires a Special Resolution be obtained for an office of a Director to be considered vacated.

About WuXi PharmaTech

WuXi PharmaTech is a leading pharmaceutical, biotechnology and medical device R&D outsourcing company, with operations in China and the United States. As a research-driven and customer-focused company, WuXi PharmaTech provides a broad and integrated portfolio of laboratory and manufacturing services throughout the drug and medical device R&D process. WuXi PharmaTech's services are designed to assist its global partners in shortening the cycle and lowering the cost of drug and medical device R&D. WuXi PharmaTech's operating subsidiaries are known as WuXi AppTec. For more information, please visit: .

    For more information, please contact:

    WuXi PharmaTech (Cayman) Inc.
     Ronald Aldridge (for investors)
     Director of Investor Relations
     Tel:   +1-201-585-2048

     Stephanie Liu (for the m
SOURCE WuXi PharmaTech (Cayman) Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2

Related biology technology :

1. WuXi PharmaTech Schedules Second-Quarter 2009 Earnings Release
2. WuXi PharmaTech Receives Award from BASF
3. WuXi PharmaTech Named a Top Ten Chinese Outsourcing Enterprise
4. WuXi PharmaTech Appoints Felix Hsu as Senior Vice President of U.S. Operations
5. WuXi PharmaTech Appoints Wei-Min Chang as Vice President of Operations and General Manager of SynTheAll Manufacturing Facility, Eric Gu as Vice President of Business Development for Manufacturing Services
6. WuXi PharmaTech to Present at Third Annual Jefferies Healthcare Conference
7. WuXi PharmaTech Schedules First-Quarter 2009 Earnings Release
8. Pharmatech Oncology Selected to Present at Company Showcase at BIOZONA
9. WuXi PharmaTech Announces Fourth-Quarter and Full-Year 2008 Results
10. The Fitzsimons Redevelopment Authority Selects Pharmatech Oncology as Preferred Vendor
11. Quest PharmaTech Announces Strategic Alliance with IntelligentNano to Develop Nanotechnology-Based Next Generation SL052
Post Your Comments:
(Date:10/7/2015)... ... October 07, 2015 , ... ... webinar titled Smart Nanostructured Coatings to provide a comprehensive overview of the innovations ... free webinar at . This webinar will be given by Professor ...
(Date:10/7/2015)... Menlo Park, CA and Yokahama, Japan (PRWEB) , ... ... ... Sugiyama Lab at RIKEN have entered into a collaborative agreement to develop a ... interactions (DDIs). , Optivia and the Sugiyama Lab will combine their respective ...
(Date:10/6/2015)... ... October 06, 2015 , ... Researchers ... microscope technology that could help surgeons work with a greater degree of accuracy. ... blood flow and cancerous tissue over real images of blood vessels and other ...
(Date:10/6/2015)... , Oct. 6, 2015  The nonprofit ... that natural ingredients manufacturer Teawolf has adopted the ... Adopt-an-Herb Program . HerbMedPro ™ database ... clinical research on guayusa, a caffeine-containing member of ... comprehensive database available on ABC,s website that provides ...
Breaking Biology Technology:
... Networks Corp. has been recognized by Microsoft ... services. , ,The Madison-based IT solutions provider this month ... Midwest to achieve Microsoft's Enterprise Project Management (EPM) specialization. ... expertise in serving businesses that require the tools and ...
... Wis. Higher revenue from its clinical molecular diagnostic products ... a loss for the quarter ending March 31, 2006. , ,Third ... of $4.4 million, or ($0.11) a diluted share, for the first ... net loss of $4.4 million, or ($0.11) a diluted share, for ...
... Wis. Fiserv, which provides software and services ... revenues in 2006 were up 13 percent to $1.1 ... from the $140 million the company made in the ... , ,Fiserve's activities in the first quarter included repurchasing ...
Cached Biology Technology:
(Date:9/28/2015)... , September 28, 2015 ... Component (Hardware & Software), Product (Scanner & Others), Application ... & Defense, & Others) & Geography Global - Forecast ... expected to reach USD 3627.90 Million by 2020, at ... Browse 65 market data T ables ...
(Date:9/24/2015)... , Sept. 24, 2015  EyeLock LLC, a ... showcasing its award winning and latest technology in Booth ... Anaheim, California . EyeLock,s iris authentication ... with unmatched biometric accuracy, making it the most proven ... platform uses video technology to deliver a fast and ...
(Date:9/10/2015)... LONDON , Sept. 10, 2015 ... This New Study Reveals Selling Opportunities and Revenue ... What,s the future of biologics, especially new drug ... You will stay ahead with exclusive market data ... can explore trends, developments, results, opportunities and sales ...
Breaking Biology News(10 mins):
... is often compared to a book. However, it is not so ... rather like a cookbook. The cell reads only those recipes which ... genes; ,reading, in the book of the cell means creating RNA ... The cell uses highly complex, sophisticated regulatory mechanisms to ...
... have created mice that can "smell" light, providing a potent ... basis of olfaction. The work, described this week in ... future study of smell and of complex perception systems that ... "It makes intuitive sense to use odors to study ...
... thousand federal, state and local leaders and physical security ... Regional Airport next May 17-19 to observe demonstrations of ... to personnel, equipment and facilities - in combat zones ... and abroad. Military and civilian representatives of ...
Cached Biology News:
... for all types of yeast two-hybrid studies, including complex ... Choice of two bait vectors for maximum ... Triple reporter strain NMY51 ... Complete set of controls: pLexA-p53, pLexA-lamin ...
... Quickly, effectively seals labware. Waterproof, ... protects anhydrous materials. Can be folded ... without rupturing. Stretched lengthwise at 21C ... Yet when tension is removed, film ...
Human Serum FDA Licensed US Donor Centers Sterile / Non-sterile: Sterile Filtered to 0.2 micron Information: Extensive Viral Testing ...
Normal human serum collected off the clot from healthy normal humans. Each donor unit is negative for anti-HIV 1&2, HIV-Ag, HCV, and HBsAg by FDA required tests...
Biology Products: